目的介绍SF-36评分系统应用于人工关节置换术患者以评估其健康状况。方法入选2012年至2014年58例全髋关节置换患者(total hip replacement,THR),131例全膝关节置换患者(total knee replacement,TKR),分别于术前和术后6个月使用SF-36量表...目的介绍SF-36评分系统应用于人工关节置换术患者以评估其健康状况。方法入选2012年至2014年58例全髋关节置换患者(total hip replacement,THR),131例全膝关节置换患者(total knee replacement,TKR),分别于术前和术后6个月使用SF-36量表,Harris量表(THR患者),膝关节学会评分(Knee Society Score,KSS)量表(TKR患者)对患者进行评估;并对评分结果进行Pearson相关分析。结果最终获得THR完整随访53例,TKR完整随访124例,相关性检验显示36条目健康调查量表(36-Item Short-Form Health Survey,SF-36)与Harris量表及KSS量表均呈显著性正相关关系(双侧,P<0.01)。结论 SF-36量表能够较好的反映人工关节置换术后患者健康状况包括生理和心理两方面的变化,应用于此类患者具有相当的效度和信度。展开更多
Objectives: Osteoarthritis (OA) has a dramatic impact on patients’ health related quality of life (HRQoL). Chronic use of analgesics and anti-inflammatory medications for pain management may improve symptoms but on l...Objectives: Osteoarthritis (OA) has a dramatic impact on patients’ health related quality of life (HRQoL). Chronic use of analgesics and anti-inflammatory medications for pain management may improve symptoms but on long term may affect HRQoL negatively. The objective of the present study was to compare the impact of two different classes of analgesics, traditional non-steroidal anti-inflammatory drugs (NSAIDs) and selective cyclo-oxygenase-2 (COX-2) inhibitors on HRQoL among osteoarthritis patients using the SF-36 questionnaire. Methods: Clinic based cross-sectional study conducted at Al-Qassimi Hospital, Sharjah, United Arab Emirates (UAE), over a period of six months. Ethical Approval was obtained from the ethics committee at Al-Qassimi Clinical Research Center. Total of 200 osteoarthritis patients fulfilling the inclusion and exclusion criteria were involved in the study. Patients’ demographics were collected from their medical records. The Medical Outcome Study Short-Form 36 (SF-36) questionnaire was used to measure patients’ HRQoL. SF-36 data were scored using health outcomes scoring software 4.5. Results: Mean age of the subjects was 62.19 ± 9.81 years with females constituting 151 (75.5%) of the patients. In general, females scored lower in most of the HRQoL domains compared to males and there was significant difference between the two groups in the mental health (p = 0.005) & mental component (p = 0.042) domains. Compared to selective COX-2 inhibitors, patients on NSAIDs scored higher on all domains of SF-36 except physical functioning. There was significant difference in mental health domain for patients treated with NSAIDs (p = 0.02). Celecoxib was only better than NSAIDs in osteoarthritis patients with more than one musculoskeletal disorders in the domain of bodily pain (p = 0.009). Conclusion: NSAIDs-treated patients did not differ significantly from celecoxib-treated patients in all domains of the SF-36 except for the mental health domain.展开更多
文摘目的介绍SF-36评分系统应用于人工关节置换术患者以评估其健康状况。方法入选2012年至2014年58例全髋关节置换患者(total hip replacement,THR),131例全膝关节置换患者(total knee replacement,TKR),分别于术前和术后6个月使用SF-36量表,Harris量表(THR患者),膝关节学会评分(Knee Society Score,KSS)量表(TKR患者)对患者进行评估;并对评分结果进行Pearson相关分析。结果最终获得THR完整随访53例,TKR完整随访124例,相关性检验显示36条目健康调查量表(36-Item Short-Form Health Survey,SF-36)与Harris量表及KSS量表均呈显著性正相关关系(双侧,P<0.01)。结论 SF-36量表能够较好的反映人工关节置换术后患者健康状况包括生理和心理两方面的变化,应用于此类患者具有相当的效度和信度。
文摘Objectives: Osteoarthritis (OA) has a dramatic impact on patients’ health related quality of life (HRQoL). Chronic use of analgesics and anti-inflammatory medications for pain management may improve symptoms but on long term may affect HRQoL negatively. The objective of the present study was to compare the impact of two different classes of analgesics, traditional non-steroidal anti-inflammatory drugs (NSAIDs) and selective cyclo-oxygenase-2 (COX-2) inhibitors on HRQoL among osteoarthritis patients using the SF-36 questionnaire. Methods: Clinic based cross-sectional study conducted at Al-Qassimi Hospital, Sharjah, United Arab Emirates (UAE), over a period of six months. Ethical Approval was obtained from the ethics committee at Al-Qassimi Clinical Research Center. Total of 200 osteoarthritis patients fulfilling the inclusion and exclusion criteria were involved in the study. Patients’ demographics were collected from their medical records. The Medical Outcome Study Short-Form 36 (SF-36) questionnaire was used to measure patients’ HRQoL. SF-36 data were scored using health outcomes scoring software 4.5. Results: Mean age of the subjects was 62.19 ± 9.81 years with females constituting 151 (75.5%) of the patients. In general, females scored lower in most of the HRQoL domains compared to males and there was significant difference between the two groups in the mental health (p = 0.005) & mental component (p = 0.042) domains. Compared to selective COX-2 inhibitors, patients on NSAIDs scored higher on all domains of SF-36 except physical functioning. There was significant difference in mental health domain for patients treated with NSAIDs (p = 0.02). Celecoxib was only better than NSAIDs in osteoarthritis patients with more than one musculoskeletal disorders in the domain of bodily pain (p = 0.009). Conclusion: NSAIDs-treated patients did not differ significantly from celecoxib-treated patients in all domains of the SF-36 except for the mental health domain.
